Patents by Inventor Yoon Yeo

Yoon Yeo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250144292
    Abstract: Methods for applying a therapeutic agent coating to an extended-wear device and the systems created thereby are disclosed. For example, a method for coating an extended-wear device using N-TIPS provides therapeutic agent coating for localized treatment in a patient using an extended-wear device for monitoring or treatment of illness or injury, wherein such methods can be used on polymeric films or within polymeric tubes.
    Type: Application
    Filed: February 15, 2023
    Publication date: May 8, 2025
    Inventors: Yun-Chu CHEN, Sarena Delvecchio HORAVA, Coralie Adele RICHARD, Monica Rixman SWINNEY, Yoon YEO
  • Patent number: 12280778
    Abstract: In an embodiment an apparatus includes a communication device configured to receive at least one of a starting point of a speed trap, an end point of the speed trap, a speed limit in the speed trap, an average speed of the vehicle, a traveling distance from the starting point of the speed trap of the vehicle, or a present speed of the vehicle, a target speed setting device configured to set a target point, to set a starting point for a target speed, and to calculate the target speed, a required acceleration calculating device configured to calculate a required acceleration, and a controller configured to control the vehicle based on at least one of the calculated target speed or the calculated required acceleration.
    Type: Grant
    Filed: October 25, 2022
    Date of Patent: April 22, 2025
    Assignees: Hyundai Motor Company, Kia Corporation
    Inventors: Sung Yoon Yeo, Seo Hyeon Park, Young Min Han, Seung Geon Moon
  • Patent number: 12280777
    Abstract: In an embodiment an apparatus for controlling a speed of a vehicle includes a communication device configured to receive at least one of a starting point of a speed trap, an end point of the speed trap, a speed limit in the speed trap, an average speed of the vehicle, a traveling distance from the starting point of the speed trap of the vehicle, or a present speed of the vehicle, a target speed setting device configured to set a target point, set a starting point for a target speed, and calculate the target speed, a required acceleration calculating device configured to calculate a required acceleration, and a controller configured to control the vehicle, based on at least one of the calculated target speed or the calculated required acceleration.
    Type: Grant
    Filed: October 26, 2022
    Date of Patent: April 22, 2025
    Assignees: Hyundai Motor Company, Kia Corporation
    Inventors: Sung Yoon Yeo, Seung Geon Moon, Seo Hyeon Park, Young Min Han
  • Publication number: 20240238214
    Abstract: Nanoconstructs and compositions comprising a nanoparticle coated with an immunoadjuvant (e.g. ATP) and comprising one or more therapeutic agents (e.g. ICD inducer) encapsulated therein; and methods for treating cancer in a subject using such nanoconstructs and compositions, as well as combination immunotherapies.
    Type: Application
    Filed: July 20, 2022
    Publication date: July 18, 2024
    Applicant: Purdue Research Foundation
    Inventors: Yoon Yeo, Soonbum Kwon
  • Publication number: 20240180849
    Abstract: The present disclosure generally relates to a composition matter and a method for cancer treatment. In particular, a composition matter as an antitumor immunotherapy comprising a polyethyleneimine derivative as an immunoadjuvant, a chemotherapeutic drug, and optional components such as a microRNA, messenger RNA, plasmid DNA, siRNA, oligonucleotide, or a cyclic dinucleotide. A method for treating a subject with a cancer by administrating a therapeutic effective amount of a composition comprising a polyethyleneimine derivative and an antitumor agent to the subject in need of relief from said cancer is also within the scope of this disclosure.
    Type: Application
    Filed: April 12, 2022
    Publication date: June 6, 2024
    Applicant: Purdue Research Foundation
    Inventors: Yoon Yeo, Jianping Wang, Fanfei Meng
  • Publication number: 20240058416
    Abstract: The present invention generally relates to a process of nanoparticle formulations and its composition matter for systemic treatment of sepsis. In particular, this invention discloses a method for preparing tannic acid-ferric nanoparticles, optionally incorporating a component of vitamin D3, coated with zwitterionic chitosan (ZWC) and polymyxin B (PMB). The invention described herein also pertains to pharmaceutical compositions and methods for the treatment of sepsis.
    Type: Application
    Filed: November 1, 2023
    Publication date: February 22, 2024
    Applicant: Purdue Research Foundation
    Inventors: Yoon Yeo, Simseok Yuk
  • Patent number: 11865158
    Abstract: The present invention generally relates to a process of nanoparticle formulations and its composition matter for systemic treatment of sepsis. In particular, this invention discloses a method for preparing tannic acid-ferric nanoparticles, optionally incorporating a component of vitamin D3, coated with zwitterionic chitosan (ZWC) and polymyxin B (PMB). The invention described herein also pertains to pharmaceutical compositions and methods for the treatment of sepsis.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: January 9, 2024
    Assignee: Purdue Research Foundation
    Inventors: Yoon Yeo, Simseok Yuk
  • Publication number: 20230414514
    Abstract: A formulation to deter abuse of a drug by smoking comprising a physical barrier having properties to entrap the drug and thermal degradation products thereof. The physical barrier is in the form of an additive or a polymer network or a combination thereof.
    Type: Application
    Filed: April 13, 2023
    Publication date: December 28, 2023
    Inventors: Luis Solorio, Anastasiia Vasiukhina, Yoon Yeo, Sheryhan F. Gad
  • Publication number: 20230404933
    Abstract: The present disclosure generally relates to a composition matter and a method for cancer treatment. In particular, a composition of soft, non-cationic nanocapsules, termed Nanosac, for systemic delivery of siRNA. Nanosac is produced by sequential attachment of siRNA and polydopamine on a sacrificial MSN core, followed by removal of the MSN. Encapsulating siRNA in the capsules, Nanosac avoids the issues common to cationic gene carriers, such as toxicity and non-specific protein binding while protecting siRNA from RNase. Nanosac entered tumor cells by caveolae-mediated endocytosis, likely via albumin recruited from serum, trafficked to the cytosol, and silenced target genes.
    Type: Application
    Filed: October 27, 2021
    Publication date: December 21, 2023
    Applicant: Purdue Research Foundation
    Inventors: Yoon Yeo, Hyungjun Kim
  • Publication number: 20230398987
    Abstract: In an embodiment an apparatus includes a communication device configured to receive at least one of a starting point of a speed trap, an end point of the speed trap, a speed limit in the speed trap, an average speed of the vehicle, a traveling distance from the starting point of the speed trap of the vehicle, or a present speed of the vehicle, a target speed setting device configured to set a target point, to set a starting point for a target speed, and to calculate the target speed, a required acceleration calculating device configured to calculate a required acceleration, and a controller configured to control the vehicle based on at least one of the calculated target speed or the calculated required acceleration.
    Type: Application
    Filed: October 25, 2022
    Publication date: December 14, 2023
    Inventors: Sung Yoon Yeo, Seo Hyeon Park, Young Min Han, Seung Geon Moon
  • Publication number: 20230398986
    Abstract: In an embodiment an apparatus for controlling a speed of a vehicle includes a communication device configured to receive at least one of a starting point of a speed trap, an end point of the speed trap, a speed limit in the speed trap, an average speed of the vehicle, a traveling distance from the starting point of the speed trap of the vehicle, or a present speed of the vehicle, a target speed setting device configured to set a target point, set a starting point for a target speed, and calculate the target speed, a required acceleration calculating device configured to calculate a required acceleration, and a controller configured to control the vehicle, based on at least one of the calculated target speed or the calculated required acceleration.
    Type: Application
    Filed: October 26, 2022
    Publication date: December 14, 2023
    Applicant: Hyundai Motor Company
    Inventors: Sung Yoon Yeo, Seung Geon Moon, Seo Hyeon Park, Young Min Han
  • Patent number: 11793982
    Abstract: Drug delivery devices that have a flexible film, an array of nanoscopic, porous needles attached to a surface of the flexible film, and a therapeutic drug cargo loaded onto the needles. The drug delivery device may be applied to living tissue such that the surface of the flexible film contacts the living tissue and some or all of the needles are inserted into the tissue. The flexible film may then be dissolved while leaving the needles inserted in the tissue. The needles degrade in the living tissue over time causing release of the therapeutic drug cargo loaded onto the needles.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: October 24, 2023
    Assignees: Purdue Research Foundation, Industry-University Cooperation Foundation Hanyang University
    Inventors: Chi Hwan Lee, Yoon Yeo, Dong Rip Kim
  • Publication number: 20230248689
    Abstract: The present invention relates to pharmaceutical formulations for long-term ocular delivery of the active agents. The present invention further provides the long-term ocular delivery of griseofulvin with specific in vitro release profile. These formulations are used for the treatment of neovascular eye diseases and age-related macular degeneration (AMD). In particular, the present invention provides microparticles & nanoparticles of griseofulvin for the long-term ocular delivery and methods of preparation of such formulations.
    Type: Application
    Filed: June 24, 2021
    Publication date: August 10, 2023
    Applicants: PURDUE RESEARCH FOUNDATION, THE TRUSTEES OF INDIANA UNIVERSITY
    Inventors: Yoon Yeo, Dhawal Chobisa, Timothy W. Corson
  • Patent number: 11670096
    Abstract: An apparatus and method for recognizing a driving lane of a vehicle are provided. The apparatus includes an information acquisition device that acquires forward information of a road on which the vehicle is driving, and a processor that recognizes an entrance section and an exit section on a front left side of the vehicle based on the forward information, and determines a driving lane of the vehicle by correcting a number of lanes of the road in the entrance section and the exit section.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: June 6, 2023
    Assignees: HYUNDAI MOTOR COMPANY, KIA MOTORS CORPORATION
    Inventors: Young Min Han, Sung Yoon Yeo, Seo Hyeon Park, Seung Geon Moon
  • Publication number: 20220401374
    Abstract: The present disclosure generally relates to a composition matter and a method for cancer treatment comprising albumin (alb) coated tannic acid-Fe nanoparticles (NPs) with a therapeutic compound, and one or more diluents, excipients or carriers. In particular, the present invention provides a treatment by enhancing antitumor immunity using tannic acid-based nanoparticles containing a therapeutic cancer treatment that can induce immunogenic cell death (ICD). The method disclosed herein provides a potential solution to the immunotoxicity accompanying the ICD cancer immunotherapy by intratumoral or intravenous administration of a nanocapsule formulation of carfilzomib (CFZ), an ICD-inducing proteasome inhibitor, using interfacial supramolecular assembly of tannic acid (TA) and iron, supplemented with albumin coating for better metabolic stability.
    Type: Application
    Filed: September 11, 2020
    Publication date: December 22, 2022
    Applicant: Purdue Research Foundation
    Inventors: Yoon Yeo, Maie S. Taha
  • Publication number: 20220288162
    Abstract: The present invention generally relates to a process of nanoparticle formulations and its composition matter for systemic treatment of sepsis. In particular, this invention discloses a method for preparing tannic acid-ferric nanoparticles, optionally incorporating a component of vitamin D3, coated with zwitterionic chitosan (ZWC) and polymyxin B (PMB). The invention described herein also pertains to pharmaceutical compositions and methods for the treatment of sepsis.
    Type: Application
    Filed: August 21, 2020
    Publication date: September 15, 2022
    Applicant: PURDUE RESEARCH FOUNDATION
    Inventors: Yoon YEO, Simseok YUK
  • Patent number: 11370427
    Abstract: The present disclosure relates to a driver assistance apparatus and a method for operating the same. The driver assistance apparatus includes a navigation device that provides a guide route and road information, a detector that measures information regarding surroundings of a vehicle, and a processor that performs a deceleration control for entrance to an exit ramp, based on the information obtained through the navigation device and the detector.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: June 28, 2022
    Assignees: HYUNDAI MOTOR COMPANY, KIA MOTORS CORPORATION
    Inventors: Sung Woo Choi, Sung Yoon Yeo
  • Publication number: 20220117895
    Abstract: The present invention generally relates to a method for preparing a drug-loaded liposome, in particular to a method for preparing a drug-loaded liposome manufactured using hypertonic loading or a combination of hypertonic loading and remote loading of one or more drugs. The invention described herein also pertains to pharmaceutical compositions and methods for treating cancers. Both the manufacturing processes and the pharmaceutical products are within the scope of this disclosure.
    Type: Application
    Filed: January 16, 2020
    Publication date: April 21, 2022
    Applicant: Purdue Research Foundation
    Inventors: Yoon Yeo, Hassan Tamam
  • Publication number: 20210386986
    Abstract: Drug delivery devices that have a flexible film, an array of nanoscopic, porous needles attached to a surface of the flexible film, and a therapeutic drug cargo loaded onto the needles. The drug delivery device may be applied to living tissue such that the surface of the flexible film contacts the living tissue and some or all of the needles are inserted into the tissue. The flexible film may then be dissolved while leaving the needles inserted in the tissue. The needles degrade in the living tissue over time causing release of the therapeutic drug cargo loaded onto the needles.
    Type: Application
    Filed: June 10, 2021
    Publication date: December 16, 2021
    Inventors: Chi Hwan Lee, Yoon Yeo, Dong Rip Kim
  • Publication number: 20210365693
    Abstract: An apparatus and method for recognizing a driving lane of a vehicle are provided. The apparatus includes an information acquisition device that acquires forward information of a road on which the vehicle is driving, and a processor that recognizes an entrance section and an exit section on a front left side of the vehicle based on the forward information, and determines a driving lane of the vehicle by correcting a number of lanes of the road in the entrance section and the exit section.
    Type: Application
    Filed: September 14, 2020
    Publication date: November 25, 2021
    Applicants: HYUNDAI MOTOR COMPANY, KIA MOTORS CORPORATION
    Inventors: Young Min HAN, Sung Yoon YEO, Seo Hyeon PARK, Seung Geon MOON